Gene therapy Archives

News and Trends 16 Oct 2015

Biotech of the week: Mologen, the Largest Publicly-listed Biotech of Berlin

This week, we're leaving Paris and heading East to a city that's 9 times bigger than the capital of France, it's also the city we all call home here at Labiotech,…

October 16, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 7 Oct 2015

Nobel Prize in Chemistry 2015: DNA Repairing Mechanisms that Keep you Alive

DNA repair mechanisms are crucial to our existence. Without them, we would not survive because of DNA damage caused by the environment (e.g UV light damage, radiation etc.). This crucial…

October 7, 2015 - 4 minutesmins - By Philip Hemme

News and Trends 5 Oct 2015

€31M goes to a 15-month old Start-up tackling the leading cause of Dwarfism

TherAchon is a 15-month old start-up from the Nice area (France) which has attracted some serious US investors as of late, drawn by their pioneering protein therapy for Achondroplasia (the…

October 5, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 28 Aug 2015

FDA shelves UniQure’s Glybera – will the Gene therapy once reach the US market?

The €1.1M drug Glybera was the first gene therapy on the European market. UniQure wants to sell it in the US too, but the FDA makes it much more difficult…

August 28, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 22 Aug 2015

What happened this week? Biotech revolutionizes Coffee, Paris N°1 Biocluster, a DNA-made Computer…

Welcome in our Top of the week list! This week is full of uncommon stories. Did you know that we can create the best coffee from Biotech techniques? The New…

August 22, 2015 - 2 minutesmins - By Joachim Eeckhout

News and Trends 20 Aug 2015

DNA to play an essential role in the future of Computers?

You can do terrific things with DNA - convicting a murderer, confirming the right father ... and building computers! As biomolecular computing is ever-growing, scientists from the University of East…

August 20, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 19 Aug 2015

Top 5 Biotech Books to Enjoy your Summer on the Beach

Summer is a great time to read books and get inspired for the year to come. Here's a Top 5 list of my recommendations to read before summer ends. 1. Genentech: The Beginnings…

August 19, 2015 - 3 minutesmins - By Philip Hemme

News and Trends 12 Aug 2015

A Tale of Love for UniQure and Bristol-Myers Squibb

In May, Bristol-Myers Squibb (BMS) nailed down the exclusive access to uniQure's gene therapy platform to treat cardiovascular diseases. Everything seems to work out fine as BMS paid $53M (€47M)…

August 12, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 4 Aug 2015

How Gene Therapy could Cure Deafness

Cochlear implants achieved a great success in the past. However, there is hope that patients suffering from hearing loss won't need to be dependent on an electronic device soon. Several…

August 4, 2015 - 4 minutesmins - By Philip Hemme

News and Trends 20 Jul 2015

Theravectys’ HIV Cure on the Road to Success

Theravectys just announced positive results of its HIV drug candidate in a phase I/II study. The therapeutic vaccine using lentivirus could be the first cure available for the 35 million people currently suffering from…

July 20, 2015 - 3 minutesmins - By Joachim Eeckhout

eye Bayer Healthcare Johns Hopkins University

News and Trends 9 Jul 2015

Vision specialist Gensight eyes a €90M IPO on NASDAQ

French Gensight intends to raise one of the biggest European IPOs on the American stock market. The gene-therapy specialist will pursue €90.6M to advance with two early-stage candidates for orphan…

July 9, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 8 Jul 2015

First Success for Imperial Innovations’ Gene Therapy in Cystic Fibrosis

Good news for patients suffering from cystic fibrosis! Imperial Innovations' patented gene therapy could improve the patients’ breathing provoking any side effects. An innovation that could help fulfill this unmet…

July 8, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 18 Jun 2015

German Viral Vector Producer SIRION pursues its American dream and opens in Boston

The biggest biocluster of the World is still attractive. Munich-based Sirion Biotech decided to open an office to establish its US presence and benefit from Boston's leading position in the gene therapy…

June 18, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 1 Jun 2015

DNA Therapeutics presents positive results for its breakthrough Advanced Cancer Therapy

ASCO Annual Meeting keeps bringing positive results of European companies that cross the ocean to present their clinical trial outcomes. DNA Therapeutics, the French biopharma, presented the results of the…

June 1, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 14 May 2015

Selecta continues its tour around France with another collaboration

Selecta Biosciences and Généthon are collaborating to enable repeat dosing for gene therapies. The companies are combining Généthon’s expertise in the development of gene therapy vectors and Selecta’s Synthetic Vaccine…

May 14, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 8 May 2015

GSK sparks off the Gene Therapy resurgence

GlaxoSmithKline has become the first big pharma company to file a gene therapy approval case to the European Medicines Agency (EMA). The therapy, developed in collaboration with San Raffaele Hospital and the Telethon…

May 8, 2015 - 4 minutesmins - By Joachim Eeckhout

News and Trends 10 Mar 2015

Live from Bio-Europe 2015: The product development challenges in the gene therapy field

Gene Therapy is really the hot topic right now in the field of Biotech especially with technologies such as CRISPR and CAR-T therapies. The value of such companies are skyrocketing and…

March 10, 2015 - 3 minutesmins - By Philip Hemme

News and Trends 5 Mar 2015

Synpromics and UniQure, new Collaboration in Gene Therapy.

Synpromics has formed a collaboration with uniQure, the Dutch pioneer in human gene therapy, to develop synthetic promoters with specific application in the delivery of gene therapies to liver. Synpromics, a…

March 5, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 22 Feb 2015

Theravectys: an Orphan Drug Designation for Its Lentiviral Vector-Based Therapeutic Vaccine

THERAVECTYS, a fully-integrated discovery and clinical development biotechnology company focusing on the development of therapeutic vaccines and immunotherapy, announced that the European Medicines Agency (EMA) has granted Orphan Drug Designation to its therapeutic vaccine candidate for the…

February 22, 2015 - 3 minutesmins - By Joachim Eeckhout

News and Trends 1 Dec 2014

The First Gene Therapy Drug Will Be Sold at Record €1,1M Price

What could you buy with €1,1M euros? A house? Or a single prescription for a new drug... The first gene therapy drug "Glybera" is set to go on sale in Germany with…

December 1, 2014 - 3 minutesmins - By Julie Lellouche

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

The Biotech Perspective 2023

View all companies A-Z

Find new scientific partnerships. Create a free IN-PART account

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inova, the leading platform for biopharma partnering